Navigation Links
XTend Medical (XDMC) Adds New Bluetooth(R) Telemedicine Products From A&D Medical
Date:10/18/2007

Bluetooth(R) Wireless Blood Pressure Cuff and Weight Scale Added to Our

Telemedicine Product Line

SUN VALLEY, Calif., Oct. 18 /PRNewswire-FirstCall/ -- XTend Medical Corporation (Pink Sheets: XMDC) announced the company has added two new Bluetooth(R) enabled telemedicine products to their line of disease management solutions for sales to managed care, hospitals, long term care facilities, and physician groups.

"The addition of A & D's Bluetooth(R) enabled Blood Pressure Cuff and Weight Scale will give us the opportunity to package our offerings to the various healthcare organizations in order to effectively monitor their patients with the most up to date technology in the healthcare arena. As we target the larger managed health care companies, this technology allows us to not only target diabetic patients, our main focus, but also gives us the ability to present to managed care companies a cutting-edge solution for chronic conditions in heart and kidney patients. This increases our opportunity to generate significant sales and imbeds us further with gaining additional long term contracts. XTend Medical, through R&D expenditures and exclusive agreements, continues to ensure our position as a leading provider of telemedicine products and services for years to come," stated Mr. Paul D. Lisenby, Chairman and CEO of XTend Medical.

About A & D:

A&D Medical is a division of A&D, an ISO 9002-registered company with operations in Asia, Europe, Australia, Russia, and North and South America. Since 1977, A&D Medical has manufactured and distributed a full line of advanced electronic blood pressure monitoring equipment and health care products for home and professional use. The company has established itself as a leader in home health monitoring technology through the development and introduction of a variety of unique products. A&D's LifeSource(R) blood pressure monitor line has garnered numerous industry awards. Recent product introductions include: the LifeSource(R) digital thermometers, personal scales, stethoscopes, and Ambulatory Blood Pressure Monitors.

For more information, please check out our website, http://www.andmedical.com.

About XTend Medical:

XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients.

For more information about the Company, please visit http://www.xtendmedical.com.

Safe Harbor: This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.

Company Contact: FutureTechIR for XTend Medical Corporation

Investor Relations

(817) 812-2105


'/>"/>
SOURCE XTend Medical Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medicare Drug Deadline not to be extended
2. Liver key to extending life
3. Regular exercise linked to extended menstrual cycles
4. Even mid-life diet change can extend life
5. Extended Therapy for Blood Clots
6. Friendship can extend lifespan
7. Genes to Extend Longevity Discovered
8. India extends National TB Control Program
9. Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac
10. Drug Courts In Europe Extended For Three More Years
11. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 10, 2016 , ... Dr. Jessica Barron, of Barron Family Dental in ... patients and families in the North Metro Denver area. The new dental practice focuses ... dentistry, and all in the most relaxing environment. , While some dental visits can ...
(Date:2/10/2016)... ... February 10, 2016 , ... United ... Nesbitt as the latest addition to its growing list of Partner Firms. ... the Southeast, from Orlando to Huntsville and in between. , Harnessing the experience ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a ... network of laboratory service centers across the country. Launched in April of 2015, Apifiny ... detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis Strupp ... book "Better with Age: The Ultimate Guide to Brain Training" by award-winning author ... The book’s publication date is March 16, 2016. A free review copy is ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has ... readily available to physicians. The integration will enable Allscripts users to post ... via Everseat’s free mobile app. , The partnership gives Everseat substantial added power ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016  The Baylor ... received an in-kind gift from ... VeinViewer® Vision vein finder for the nursing ... students as they learn how to start ... with traditional technique. ...
(Date:2/10/2016)... Feb. 10, 2016  Visage Imaging Inc. ("Visage"), ... (ASX: PME), has announced that the American College of ... have selected the Visage 7 Enterprise Imaging Platform ... Emergent/Critical Care Imaging SIMulation (SIM). SIM is the ... Program (WIDI), a multi-faceted and fully-integrated online assessment, ...
(Date:2/10/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... cell disease and heart failure, today announced the pricing ... a price to the public of $0.275 per unit. ... common stock and one warrant to purchase one share ... of $0.42 per share. The warrants are exercisable six ...
Breaking Medicine Technology: